Please login to the form below

Not currently logged in
Email:
Password:

This Month

This page shows the latest This Month news and features for those working in and with pharma, biotech and healthcare.

CEOs agree to Congressional grilling on US drug prices

CEOs agree to Congressional grilling on US drug prices

later this month. ... The President is calling for greater more drug pricing transparency, and HHS Secretary Alex Azar recently announced plans to ban drug rebates between pharma and PBMs, though this move would hit

Latest news

  • Novartis aims for 10 blockbuster launches by 2020 Novartis aims for 10 blockbuster launches by 2020

    The company also announced cuts to its manufacturing operations, and confirmed the spin off of eyecare division Alcon, which could raise as much as $35bn this year. ... The company has a new head of its oncology division, Susanne Schaffert, who took up

  • Ministerial revolt looming over ‘no-deal’ Brexit risk Ministerial revolt looming over ‘no-deal’ Brexit risk

    There are no WTO rules – this is one of the fictions and fallacies,” he asserted. ... of her own proposal, despite its comprehensive defea t in the Commons earlier this month, and concentrating on persuading her own party to back this rather than

  • European biosimilars hit AbbVie’s Humira revenues in Q4 European biosimilars hit AbbVie’s Humira revenues in Q4

    It also reflects moves by AbbVie to retain market share by lowering the price on Humira, this strategy being confirmed in England, where the NHS was quick to exploit the new ... M&A rumours in the sector have taken on more credibility since BMS acquired

  • EMA says Lilly’s Lartruvo should not be prescribed EMA says Lilly’s Lartruvo should not be prescribed

    Staying on the market depended on a confirmatory phase 3 trial, however, and earlier this month Lilly revealed that study – called ANNOUNCE – missed the mark. ... The company took a further step down the oncology-building path earlier this month when

  • Evenity back on track with FDA panel blessing in osteoporosis Evenity back on track with FDA panel blessing in osteoporosis

    Amgen has already secured its first marketing approval for Evenity (romosozumab) – in Japan earlier this month – and with US approval seemingly assured now has the successor it needs for its $2bn

More from news
Approximately 16 fully matching, plus 552 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    This month sees Lisa taking her years of experience to a fresh new challenge, leaving ‘big pharma’ to become chief executive of Redx, a promising UK biotech company focused on novel ... As she wrote in a blog to mark International Women’s Day on 8

  • Digital health Digital health

    Companies that embrace this fast and hard will access better outcomes and improve population management.”. ... The solution, which combines tools based in cognitive behavioural theory, mindfulness, optimism and gratitude is firmly grounded in

  • Ten years at the forefront of patient experience Ten years at the forefront of patient experience

    This month marks ten years of Hive, which has prompted us to reflect on how the world has changed over the last decade, and how it is going to change over ... in the future; the fact that the phrase ‘customer experience (CX)’ has reached the pharma

  • Deal Watch January 2018

    tell. Three companies have been particularly active in deal making this month: Sanofi, Celgene and Takeda - more on this below. ... Celgene back in acquisition mode. While Sanofi led the way with a committed spend of $16.4bn in January, Celgene also had

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... This is a turning point for Parkinson’s.”. The success of BlueSky is important for both companies.

More from intelligence
Approximately 0 fully matching, plus 102 partially matching documents found.

Latest appointments

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    Adam Raff, Director, Translational Medicine Unit, Leo Pharma. He is due to start towards the end of this month, and will support Leo’s ambitions to advance science within dermatology through ... With the phase 3 trial of Nefecon well underway, this is

  • Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more

    later this month. ... Prior to this, she has held senior roles for other agencies including Virgo, Weber Shandwick and Inventiv Health.

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Boerner takes over from Murdo Gordon (below), who jumped ship earlier this month to join Amgen as its executive vice president of global commercial operations. ... Prior to this, Davies served in various roles at Savient Pharmaceuticals and Boehringer

  • Dr Paula Salmikangas joins NDA Group Dr Paula Salmikangas joins NDA Group

    Dr Salmikangas is the second recent senior appointment at NDA Group following the appointment of Dr Van den Eynde, who joined earlier this month as its new vice president.

  • Maxor appoints new chief executive officer Maxor appoints new chief executive officer

    Mike Ellis succeeds John Ward. Maxor National Pharmacy Services has appointed Mike Ellis as its new chief executive officer, replacing John Ward who retired earlier this month. ... He established a strong culture at the Company and contributed

More from appointments
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • 20 questions: Round 7

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month "What project or event has been most memorable to you at

  • 20 questions: Round 6

    As it's our 20th year anniversary, we invited our employees to play our version of 20 questions - this month we asked our employees about office life in Singapore.

  • Patient outcomes in practice: delivering value that transforms lives

    In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. ... The vision is there, but it requires translation of this

  • Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK

    The UK’s best performing market research agencies were revealed earlier this month with the publication of Research Live’s Industry Report for 2019, which includes the latest Market Research Society ... Mark commented, “We are delighted to see

  • GCI Health Expands into Asia to Meet Growing Demand

    She will relocate from London to Singapore later this month. “With Asian healthcare systems and markets rapidly evolving, the need for specialist agency expertise does too,” said Wendy Lund, CEO.

More from PMHub
Approximately 0 fully matching, plus 60 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics